BUSINESS
Hero MotoCorp Q2FY24: Improving rural demand, input price correction boost margins
Hero MotoCorp has been exploring opportunities in the electric vehicle (EV) space as well. The company has launched its EV vehicle and is clocking a run rate of 1,000 units per week.
BUSINESS
UPL Q2 FY24: A quarter where the bad turned ugly
High channel inventory, dismal pricing, weak cashflows, high leverage – all came together to hurt the overall business. In fact, a lot of things will have to improve before we could see a reason for any rerating
BUSINESS
Mamaearth IPO: Are you paying the right price to look good?
Honasa is trading at a valuation in line with its peers in similar businesses notching up significantly higher margins
BUSINESS
Rallis India: New opportunity in the offing
Long-term business potential is not affected by near-term headwinds
BUSINESS
Sharda Cropchem continues to wobble
The near-term outlook is rather weak and doesn’t present an appealing investment opportunity
BUSINESS
Hindustan Unilever: Road to recovery likely to be gradual
Gradual rural recovery and softening of commodity prices to aid margin gains, to be partly offset by higher spends on advertisement
BUSINESS
Sumitomo Chemical India: Limited opportunities in the near term
A company with a healthy balance sheet and an R&D-focused parentage, but growth in the exports market will be slow
BUSINESS
Dhanuka Agritech: The overcast condition is clearing
Growth opportunities have become more visible now and short-term concerns weigh less
BUSINESS
Sharda Cropchem: Why are we playing it safe?
The near-term outlook is rather weak and doesn’t present an appealing investment opportunity
BUSINESS
Zaggle IPO: Should you subscribe to it?
Zaggle doesn't have a comparable listed peer in India. Its international peers generate significantly higher margins, but trade at a lower valuation
BUSINESS
Krsnaa Diagnostics: Approaching an inflection point
The company has a solid and differentiated business model, with promising growth potential
BUSINESS
Jupiter Life Line Hospitals IPO: Can it make your healthcare portfolio come alive?
The IPO is perfectly priced. Long-term growth is supported by demand-supply gap in the company‘s focused region
BUSINESS
KIMS: A guidebook for investors after the stellar stock run
KIMS is well-positioned to seize the growing demand for healthcare facilities in the country. Timely execution and ramp-up of new projects will be key.
BUSINESS
Vijaya Diagnostic Centre: A wider footprint with an eye on margins
Steady growth profile, strong regional presence, and a higher focus on radiology give the company an edge in a highly competitive industry.
BUSINESS
Global Health: Ramp-up in new hospitals to support earnings growth
Medanta is cementing its footprint in north India. Its aggressive expansion plans reflect the growing demand and the opportunities for high-end healthcare facilities in the country
BUSINESS
Apollo Hospital: Profitability of non-hospital businesses remains a key concern
A credible profitability roadmap for pharmacy is the ask. Although AHEL has the potential to leverage its presence across the entire spectrum of hospitals, pharmacy, and diagnostics, we remain cautious
BUSINESS
PI Industries: Solid execution despite sectoral woes
The company, with superior execution and a solid business model, is on track to achieve its long-term strategic objectives
BUSINESS
Max Healthcare: We are trimming our optimism
Expansion plan supports growth momentum. However, valuations have turned quite high
BUSINESS
Paradeep Phosphate: A long-term opportunity in fertiliser space
FY24/25 to gain from cost efficiencies and improved capacity for this fertiliser player
BUSINESS
Concord Biotech IPO: A differentiated API portfolio to play the China+1 opportunity
The business warrants attention due to superior financials, barriers to entry, and significant market share for key molecules
BUSINESS
UPL: Near-term outlook clouded
Improvement in industry dynamics and continued efforts to reduce debt level will be key to growth
BUSINESS
Coromandel International Q1FY24: Twinkled amidst challenging times
Emerging business segments hold good potential and are likely to be value-accretive.
BUSINESS
Yatharth Hospitals IPO: Wait for a more differentiated business model to emerge
The bulk of the business comes from the NCR region, which is a crowded market for hospitals. Hence, investors looking for long-term gains should wait
BUSINESS
Rallis India: Long-term story in place despite near-term headwinds
We see an improvement in Rallis’ business in FY24-25 and view the current valuation as an opportunity for long-term gains.
